BridgeBio Pharma, Inc. $BBIO Shares Bought by Price T Rowe Associates Inc. MD
MarketBeat
Price T Rowe Associates Inc. MD increased its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 17.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,164,967 shares of the company's stock
NASDAQ:BBIO